Status: Recruiting
A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function
This is a single-center, non-randomized, open-label, parallel-group study. It will test D-2570 in people with liver problems and in people with healthy livers, to see how the drug moves through the body and whether it is safe.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: InventisBio Co., LtdUpdated: Jul 20, 2026Locations: 1
Eligibility criteria
Voluntarily participate in this study and sign the written informed consent form... [+5]
Have undergone any prior surgery that may affect drug absorption, distribution,... [+5]